Related Experiment Videos
Therapeutic challenges. Prenatal and paediatric safety considerations
1Division of Clinical Pharmacology/Toxicology, Children's Hospital of Michigan, Detroit.
Drug Safety
|January 1, 1990
Summary
Children and fetuses face unique drug risks due to developmental changes. Thorough drug testing in pediatric populations is crucial for ensuring medication safety and efficacy.
Area of Science:
- Pharmacology
- Developmental Biology
- Pediatric Medicine
Background:
- Fetal and child development create unique susceptibilities to drug toxicities.
- Maternal drug administration during pregnancy poses risks of teratogenesis.
- Drug excretion into breast milk requires careful consideration for infant safety.
Purpose of the Study:
- To highlight the unique risks of drug toxicity in developing individuals.
- To emphasize the need for adequate drug safety and efficacy studies in children.
- To advocate for collaborative efforts in pediatric drug testing.
Main Methods:
- Review of developmental pharmacology principles.
- Analysis of drug transfer to the fetus and infant.
- Discussion of challenges in pediatric drug research.
Main Results:
- Animal studies are unreliable predictors of human teratogenesis.
- Most drugs are safe in breast milk, but exceptions exist.
- Altered drug metabolism and elimination in children necessitate age-specific safety data.
Conclusions:
- Pediatric drug safety requires establishing efficacy and safety across different age groups.
- Ethical and technical challenges in pediatric studies increase costs but are essential.
- A collaborative approach among researchers, regulators, and industry is vital for testing drugs in children.